Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
3.968
-0.072 (-1.78%)
At close: Sep 17, 2025, 4:00 PM EDT
3.950
-0.018 (-0.45%)
After-hours: Sep 17, 2025, 4:04 PM EDT
Profound Medical Revenue
Profound Medical had revenue of $2.21M in the quarter ending June 30, 2025, a decrease of -0.99%. This brings the company's revenue in the last twelve months to $11.84M, up 59.81% year-over-year. In the year 2024, Profound Medical had annual revenue of $10.68M with 48.35% growth.
Revenue (ttm)
$11.84M
Revenue Growth
+59.81%
P/S Ratio
10.00
Revenue / Employee
$83,380
Employees
142
Market Cap
118.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.68M | 3.48M | 48.35% |
Dec 31, 2023 | 7.20M | 518.00K | 7.75% |
Dec 31, 2022 | 6.68M | -192.00K | -2.79% |
Dec 31, 2021 | 6.87M | -431.00K | -5.90% |
Dec 31, 2020 | 7.30M | 3.13M | 74.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
PROF News
- 20 days ago - Profound Medical to Participate in Lake Street's 9th Annual Best Ideas Growth Conference - GlobeNewsWire
- 4 weeks ago - Profound Medical: Smokes Is Everywhere, Initiate At Sell - Seeking Alpha
- 4 weeks ago - Profound Medical Corp. (PROF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Profound Medical Announces Second Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow - GlobeNewsWire
- 4 months ago - Profound Medical Annual General and Special Meeting of Shareholders Voting Results - GlobeNewsWire
- 4 months ago - Profound Medical Corporation (PROF) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 5 months ago - Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire